Pathogenic Germline Variants in 10,389 Adult Cancers

نویسندگان

  • Kuan-lin Huang
  • R. Jay Mashl
  • Yige Wu
  • Deborah I. Ritter
  • Jiayin Wang
  • Clara Oh
  • Marta Paczkowska
  • Sheila Reynolds
  • Matthew A. Wyczalkowski
  • Ninad Oak
  • Adam D. Scott
  • Michal Krassowski
  • Andrew D. Cherniack
  • Kathleen E. Houlahan
  • Reyka Jayasinghe
  • Liang-Bo Wang
  • Daniel Cui Zhou
  • Di Liu
  • Song Cao
  • Young Won Kim
  • Amanda Koire
  • Joshua F. McMichael
  • Vishwanathan Hucthagowder
  • Tae-Beom Kim
  • Abigail Hahn
  • Chen Wang
  • Michael D. McLellan
  • Fahd Al-Mulla
  • Kimberly J. Johnson
  • Olivier Lichtarge
  • Paul C. Boutros
  • Benjamin Raphael
  • Alexander J. Lazar
  • Wei Zhang
  • Michael C. Wendl
  • Ramaswamy Govindan
  • Sanjay Jain
  • David Wheeler
  • Shashikant Kulkarni
  • John F. Dipersio
  • Jüri Reimand
  • Funda Meric-Bernstam
  • Ken Chen
  • Ilya Shmulevich
  • Sharon E. Plon
  • Feng Chen
  • Li Ding
چکیده

We conducted the largest investigation of predisposition variants in cancer to date, discovering 853 pathogenic or likely pathogenic variants in 8% of 10,389 cases from 33 cancer types. Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma. The 659 predisposition variants and 18 additional large deletions in tumor suppressors, including ATM, BRCA1, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events. We also discovered 33 such variants in oncogenes, including missenses in MET, RET, and PTPN11 associated with high gene expression. We nominated 47 additional predisposition variants from prioritized VUSs supported by multiple evidences involving case-control frequency, loss of heterozygosity, expression effect, and co-localization with mutations and modified residues. Our integrative approach links rare predisposition variants to functional consequences, informing future guidelines of variant classification and germline genetic testing in cancer.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.

OBJECTIVES To determine the frequency of pathogenic inherited mutations in 157 select genes from patients with metastatic castrate-resistant prostate cancer (mCRPC). DESIGN Observational. SETTING Multisite US-based cohort. PARTICIPANTS Seventy-one adult male patients with histological confirmation of prostate cancer, and had progressive disease while on androgen deprivation therapy. RES...

متن کامل

Association of a New Germline Variant in the MUTYH DNA Glycosylase Gene with Colorectal Adenoma Transformation into Malignancy

Background: MUTYH DNA glycosylase germline mutations are linked to the recessive inheritance of multiple adenoma. Studies have revealed that germline mutations in this gene are ethnicity related. This study aimed to identify the germline mutations in MUTYH gene and determine their prevalence among Jordanian patients with colorectal adenoma. Methods: In this study, 150 colorectal adenoma patient...

متن کامل

BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing.

BRCA mutated ovarian cancers respond better to platinum-based therapy and to the recently approved PARP-inhibitors. There is the need for efficient and timely methods to detect both somatic and germline mutations using formalin-fixed paraffin-embedded (FFPE) tissues and commercially available technology. We used a commercial kit exploring all exons and 50bp exon-intron junctions of BRCA1 and BR...

متن کامل

Simultaneous detection of genetic and copy number alterations in BRCA1/2 genes

Germline mutations in BRCA1 and BRCA2 genes (BRCA1/2) predispose to hereditary breast and ovarian cancer syndrome (HBOC), and their dysregulation increases the risk of cancers. The detection of pathogenic BRCA1/2 variants is essential for the diagnosis and prevention of HBOC, and for offering treatment decisions for patients. Therefore, there is a growing demand for the development of accurate,...

متن کامل

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.

OBJECTIVE To investigate the potential contribution of germline sequence alterations in the BAP1 gene in uveal melanoma (UM) patients with possible predisposition to hereditary cancer. DESIGN A total of 53 unrelated UM patients with high risk for hereditary cancer and five additional family members of one proband were studied. Mutational screening was carried out by direct sequencing. RESUL...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Cell

دوره 173  شماره 

صفحات  -

تاریخ انتشار 2018